These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3838315)

  • 21. Characteristics of the chemotactic activity of heparin cofactor II proteolysis products.
    Hoffman M; Pratt CW; Corbin LW; Church FC
    J Leukoc Biol; 1990 Aug; 48(2):156-62. PubMed ID: 2196322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of chemotactic peptides by neutrophil degradation of heparin cofactor II.
    Corbin LW; Church FC; Hoffman M
    Thromb Res; 1990 Jan; 57(1):77-85. PubMed ID: 2300926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
    Maimone MM; Tollefsen DM
    J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin cofactor II-proteinase reaction products exhibit neutrophil chemoattractant activity.
    Hoffman M; Pratt CW; Brown RL; Church FC
    Blood; 1989 May; 73(6):1682-5. PubMed ID: 2713501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins.
    Petzelbauer E; Seiffert D; Beckmann R; Pusch B; Geiger M; Binder BR
    Thromb Res; 1992 Jun; 66(5):559-67. PubMed ID: 1381850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma.
    Tollefsen DM; Majerus DW; Blank MK
    J Biol Chem; 1982 Mar; 257(5):2162-9. PubMed ID: 6895893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carboxylate polyanions accelerate inhibition of thrombin by heparin cofactor II.
    Church FC; Treanor RE; Sherrill GB; Whinna HC
    Biochem Biophys Res Commun; 1987 Oct; 148(1):362-8. PubMed ID: 3675584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
    Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
    Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
    Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of heparin cofactor II with neutrophil elastase and cathepsin G.
    Pratt CW; Tobin RB; Church FC
    J Biol Chem; 1990 Apr; 265(11):6092-7. PubMed ID: 2318847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.
    Tollefsen DM; Peacock ME; Monafo WJ
    J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of heparin cofactor II by calcium spirulan.
    Hayakawa Y; Hayashi T; Lee JB; Ozawa T; Sakuragawa N
    J Biol Chem; 2000 Apr; 275(15):11379-82. PubMed ID: 10753952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition.
    Mitchell JW; Church FC
    J Biol Chem; 2002 May; 277(22):19823-30. PubMed ID: 11856753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II.
    Shirk RA; Church FC; Wagner WD
    Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1138-46. PubMed ID: 8792767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mapping of the thrombin-heparin cofactor II complex.
    Fortenberry YM; Whinna HC; Gentry HR; Myles T; Leung LL; Church FC
    J Biol Chem; 2004 Oct; 279(41):43237-44. PubMed ID: 15292227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of heparin cofactor II in the modulation of hemostasis.
    Salem HH; Thompson EA
    Dev Biol Stand; 1987; 67():67-72. PubMed ID: 3301469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II.
    Yamagishi R; Koide T; Sakuragawa N
    FEBS Lett; 1987 Dec; 225(1-2):109-12. PubMed ID: 3691797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin cofactor II modulates the response to vascular injury.
    Tollefsen DM
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):454-60. PubMed ID: 17194895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.